(Q40841598)

24 September 2017

title

Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifen (English)

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

24 September 2017

1 reference

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

22 August 2023

1 reference

A. U. Buzdar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6180820

22 August 2023

K. C. Powell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6180820

22 August 2023

S. S. Legha

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6180820

22 August 2023

G. R. Blumenschein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6180820

22 August 2023

language of work or name

English

0 references

publication date

1 November 1982

1 reference

full work available at URL

24 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

22 August 2023

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

22 August 2023

1 reference

24 September 2017

volume

50

1 reference

24 September 2017

issue

9

1 reference

24 September 2017

page(s)

1708-1712

1 reference

Hypophysectomy in Metastatic Breast Cancer

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819821101%2950%3A9%3C1708%3A%3AAID-CNCR2820500909%3E3.0.CO%3B2-8

Assessment of response to therapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819821101%2950%3A9%3C1708%3A%3AAID-CNCR2820500909%3E3.0.CO%3B2-8

HYPOPHYSECTOMY IN ADVANCED BREAST CANCER

21 January 2018

2

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

Severe liver dysfunction during nicotinic acid therapy

22 August 2023

3

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

Indications for castration and adrenalectomy for advanced breast cancer

22 August 2023

7

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

Bilateral adrenalectomy in metastatic mammary cancer. An analysis of sixty-four cases.

22 August 2023

8

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

The use of prednisolone in the treatment of disseminated breast carcinoma

22 August 2023

10

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

A comparative evaluation of adrenalectomy and cortisone in the treatment of advanced mammary carcinoma

22 August 2023

11

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

The effects of DDD (1, 1-dichloro-2, 2-bis-(p-chlorophenyl)ethane) on the human adrenal; attempts to use an adrenal-destructive agent in the treatment of disseminated mammary and prostatic cancer.

22 August 2023

12

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

22 August 2023

13

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

Preliminary trial of aminoglutethimide in breast cancer

22 August 2023

14

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer

22 August 2023

15

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

Aminoglutethimide in treatment of metastatic breast carcinoma

22 August 2023

16

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

22 August 2023

17

4

323

Koelmeyer

1978

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

A comparative trial of transsphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancer

22 August 2023

18

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

Influence of estrogen receptor status on response of metastatic breast cancer to aminoglutethimide therapy

22 August 2023

20

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma

22 August 2023

21

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

Tamoxifen (antiestrogen) therapy in advanced breast cancer

22 August 2023

22

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

Tamoxifen. Use in treatment of metastatic breast cancer refractory to combination chemotherapy

22 August 2023

23

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

Nonparametric Estimation from Incomplete Observations

22 August 2023

25

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

22 August 2023

26

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

Comparison of tamoxifen and hypophysectomy in breast cancer treatment

22 August 2023

27

1 reference

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(19821101)50:9%3C1708::AID-CNCR2820500909%3E3.0.CO;2-8

22 August 2023

Identifiers

10.1002/1097-0142(19821101)50:9<1708::AID-CNCR2820500909>3.0.CO;2-8

1 reference

24 September 2017

1 reference